NKX3-2
Basic information
Region (hg38): 4:13540830-13544508
Previous symbols: [ "BAPX1" ]
Links
Phenotypes
GenCC
Source:
- spondylo-megaepiphyseal-metaphyseal dysplasia (Moderate), mode of inheritance: AR
- spondylo-megaepiphyseal-metaphyseal dysplasia (Strong), mode of inheritance: AR
- spondylo-megaepiphyseal-metaphyseal dysplasia (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spondylo-megaepiphyseal-metaphyseal dysplasia | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 3925497; 13680008; 20004766 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
- Spondylo-megaepiphyseal-metaphyseal dysplasia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NKX3-2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 42 | 48 | ||||
missense | 76 | 86 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 3 | 5 | |||
non coding | 8 | |||||
Total | 3 | 1 | 77 | 55 | 10 |
Highest pathogenic variant AF is 0.00000657
Variants in NKX3-2
This is a list of pathogenic ClinVar variants found in the NKX3-2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-13541817-A-G | Benign (Jul 03, 2019) | |||
4-13542008-G-A | Likely benign (Nov 06, 2023) | |||
4-13542026-G-A | Likely benign (Sep 29, 2022) | |||
4-13542053-C-G | not specified | Benign (Jan 06, 2025) | ||
4-13542066-G-T | Uncertain significance (Jul 29, 2022) | |||
4-13542076-G-C | Likely benign (Dec 03, 2024) | |||
4-13542089-G-A | NKX3-2-related disorder | Likely benign (Mar 14, 2019) | ||
4-13542089-G-T | Likely benign (Dec 10, 2023) | |||
4-13542097-G-C | Inborn genetic diseases | Uncertain significance (Apr 17, 2024) | ||
4-13542108-C-T | Inborn genetic diseases | Uncertain significance (Dec 09, 2023) | ||
4-13542112-G-T | Inborn genetic diseases | Uncertain significance (Jun 17, 2024) | ||
4-13542113-C-A | Likely benign (Feb 14, 2020) | |||
4-13542113-C-T | Likely benign (Nov 01, 2024) | |||
4-13542122-T-C | Conflicting classifications of pathogenicity (Nov 18, 2024) | |||
4-13542128-G-A | Likely benign (Jan 09, 2023) | |||
4-13542134-G-C | Likely benign (May 06, 2024) | |||
4-13542135-C-A | Inborn genetic diseases | Uncertain significance (May 17, 2023) | ||
4-13542152-G-A | Likely benign (Sep 01, 2021) | |||
4-13542166-C-A | Inborn genetic diseases | Uncertain significance (Nov 11, 2024) | ||
4-13542173-C-A | Likely benign (Oct 17, 2024) | |||
4-13542206-G-A | Likely benign (Oct 30, 2024) | |||
4-13542275-G-A | Likely benign (Jul 16, 2023) | |||
4-13542278-C-T | Likely benign (Mar 23, 2022) | |||
4-13542284-T-A | Likely benign (Apr 03, 2024) | |||
4-13542295-G-A | NKX3-2-related disorder | Uncertain significance (Jul 05, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NKX3-2 | protein_coding | protein_coding | ENST00000382438 | 2 | 4221 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.638 | 0.356 | 123278 | 0 | 2 | 123280 | 0.00000811 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.596 | 193 | 171 | 1.13 | 0.00000790 | 2017 |
Missense in Polyphen | 54 | 58.171 | 0.92829 | 710 | ||
Synonymous | -1.71 | 98 | 78.7 | 1.25 | 0.00000400 | 724 |
Loss of Function | 2.20 | 1 | 7.52 | 0.133 | 3.21e-7 | 101 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000144 | 0.0000474 |
European (Non-Finnish) | 0.00000973 | 0.00000904 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional repressor that acts as a negative regulator of chondrocyte maturation. PLays a role in distal stomach development; required for proper antral-pyloric morphogenesis and development of antral-type epithelium. In concert with GSC, defines the structural components of the middle ear; required for tympanic ring and gonium development and in the regulation of the width of the malleus (By similarity). {ECO:0000250}.;
- Pathway
- Endochondral Ossification;Transcriptional regulation by RUNX2;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Regulation of RUNX2 expression and activity
(Consensus)
Recessive Scores
- pRec
- 0.141
Haploinsufficiency Scores
- pHI
- 0.285
- hipred
- N
- hipred_score
- 0.490
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.925
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nkx3-2
- Phenotype
- embryo phenotype; respiratory system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- nkx3.2
- Affected structure
- pharyngeal arch 1
- Phenotype tag
- abnormal
- Phenotype quality
- absent
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;skeletal system development;transcription by RNA polymerase II;determination of left/right symmetry;cell differentiation;pancreas development;negative regulation of chondrocyte differentiation;middle ear morphogenesis;negative regulation of apoptotic process;positive regulation of transcription by RNA polymerase II;spleen development;animal organ formation;skeletal system morphogenesis;embryonic skeletal system development;intestinal epithelial cell development
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;sequence-specific DNA binding